Answers are grounded in this paper and cite their sources.
Shows the efficacy of glucocorticoids in managing juvenile dermatomyositis, suggesting the need for ongoing treatment.
Juvenile dermatomyositis is a rare autoimmune inflammatory myopathy characterized by progressive proximal muscle weakness and distinctive skin manifestations. Imaging, particularly MRI, plays a crucial role in diagnosis and monitoring, detecting muscle edema, inflammation, and chronic atrophy. Calcinosis is a common complication, particularly in children, and serves as a marker of disease progression. Treatment primarily involves glucocorticoids, with immunosuppressive agents used to minimize long-term steroid exposure. While remission is achievable, ongoing management is necessary to prevent relapses and complications.
No takes yet. Share an insight, caveat, or question.
Fatah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: